KRAS and BRAF Mutation Analysis in Colorectal Adenocarcinoma Specimens with a Low Percentage of Tumor Cells

por Lewandowska, Marzena Anna, Jóźwicki, Wojciech, Żurawski, Bogdan
Publicado 2013

A systemic literature review of neuroimaging studies in women with breast cancer treated with adjuvant chemotherapy

por Andryszak, Paulina, Wiłkość, Monika, Izdebski, Paweł, Żurawski, Bogdan
Publicado 2017

Verbal fluency in breast cancer patients treated with chemotherapy

por Andryszak, Paulina, Wiłkość, Monika, Żurawski, Bogdan, Izdebski, Paweł
Publicado 2016

Impact of Specific KRAS Mutation in Exon 2 on Clinical Outcome of Chemotherapy- and Radiotherapy-Treated Colorectal Adenocarcinoma Patients

por Roszkowski, Krzysztof, Zurawski, Bogdan, Jozwicki, Wojciech, Basta, Pawel, Lewandowska, Marzena Anna
Publicado 2014

Potential Role of Methylation Marker in Glioma Supporting Clinical Decisions

por Roszkowski, Krzysztof, Furtak, Jacek, Zurawski, Bogdan, Szylberg, Tadeusz, Lewandowska, Marzena A.
Publicado 2016

Detection of somatic mutations in ctDNA derived from adenocarcinoma patients – EGFR tyrosine kinase inhibitor monitoring preliminary study

por Lewandowska, Marzena Anna, Nalejska, Ewelina, Żołna, Łukasz, Chrząstek, Aleksandra, Żurawski, Bogdan, Wiśniewska, Magdalena, Las-Jankowska, Manuela, Roszkowski, Krzysztof, Kowalewski, Janusz
Publicado 2019

Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registr...

por Bjartell, Anders, Costa, Luis, Kramer, Gero, Zurawski, Bogdan, Galli, Luca, Werbrouck, Patrick, Ecke, Thorsten, Parikh, Omi, Bennamoun, Mostefa, Garcia Freire, Camilo, Peer, Avivit, Ljungberg, Börje, Cicin, Irfan, Smith, Emma, Lukac, Martin, Wapenaar, Robert, Chowdhury, Simon
Publicado 2022

Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Tri...

por Motzer, Robert J., Russo, Paul, Grünwald, Viktor, Tomita, Yoshihiko, Zurawski, Bogdan, Parikh, Omi, Buti, Sebastiano, Barthélémy, Philippe, Goh, Jeffrey C., Ye, Dingwei, Lingua, Alejo, Lattouf, Jean-Baptiste, Albigès, Laurence, George, Saby, Shuch, Brian, Sosman, Jeffrey, Staehler, Michael, Vázquez Estévez, Sergio, Simsek, Burcin, Spiridigliozzi, Julia, Chudnovsky, Aleksander, Bex, Axel
Publicado 2023

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

por Chi, Kim N., Rathkopf, Dana, Smith, Matthew R., Efstathiou, Eleni, Attard, Gerhardt, Olmos, David, Lee, Ji Youl, Small, Eric J., Pereira de Santana Gomes, Andrea J., Roubaud, Guilhem, Saad, Marniza, Zurawski, Bogdan, Sakalo, Valerii, Mason, Gary E., Francis, Peter, Wang, George, Wu, Daphne, Diorio, Brooke, Lopez-Gitlitz, Angela, Sandhu, Shahneen
Publicado 2023

Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651

por Haddad, Robert I., Harrington, Kevin, Tahara, Makoto, Ferris, Robert L., Gillison, Maura, Fayette, Jerome, Daste, Amaury, Koralewski, Piotr, Zurawski, Bogdan, Taberna, Miren, Saba, Nabil F., Mak, Milena, Kawecki, Andrzej, Girotto, Gustavo, Alvarez Avitia, Miguel Angel, Even, Caroline, Toledo, Joaquin Gabriel Reinoso, Guminski, Alexander, Müller-Richter, Urs, Kiyota, Naomi, Roberts, Mustimbo, Khan, Tariq Aziz, Miller-Moslin, Karen, Wei, Li, Argiris, Athanassios
Publicado 2023